ELIEM THERAPEUTICS INC (ELYM) Top Institutional Shareholders

ELIEM THERAPEUTICS INC (ELYM) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $207.80M in ELYM holdings during the latest filing period.

Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of ELYM tracked by InsiderSet, reporting ownership valued at approximately $77.41M in its March 31, 2026 SEC Form 13F filing.

The top 10 institutional shareholders tracked on this page collectively account for approximately 74% of the total disclosed ELYM value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Mpm Bioimpact Llc, Braidwell Lp, and several other long-term asset managers with concentrated positions in ELIEM THERAPEUTICS INC (ELYM).

This page ranks the largest institutional ELYM shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

78

Total Reported Value

$207.80M

Largest Holder

Ra Capital Management, L.P.

Largest Position

$77.41M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

91

Funds Exiting Positions

0

Page 1 of 2
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Ra Capital Management, L.P.0.82%11,300,939$77,411,432
Mpm Bioimpact Llc1.37%2,593,439$17,765,057
Braidwell Lp0.35%1,529,675$10,478,274
Great Point Partners Llc2.24%1,334,130$9,138,791
Millennium Management Llc0.01%1,276,260$8,742,381
Vanguard Capital Management Llc0.00%1,178,659$8,073,814
Kynam Capital Management, Lp0.44%1,003,341$6,872,886
Marshall Wace, Llp0.01%773,123$5,295,892
Affinity Asset Advisors, Llc0.28%700,000$4,795,000
Silverarc Capital Management, Llc0.55%684,908$4,691,620
Driehaus Capital Management Llc0.03%600,946$4,116,480
Adar1 Capital Management, Llc0.25%597,662$4,093,985
Nan Fung Trinity (Hk) Ltd0.32%420,517$2,880,541
Sphera Funds Management Ltd.0.49%419,247$2,871,842
Blackrock, Inc.0.00%401,649$2,751,296
Susquehanna International Group, Llp0.00%387,403$2,653,711
Citadel Advisors Llc0.00%345,663$2,367,791
Geode Capital Management, Llc0.00%312,999$2,145,106
Two Sigma Investments, Lp0.00%310,606$2,127,651
Diadema Partners Lp0.81%286,126$1,959,963
Td Asset Management Inc0.00%250,102$1,713,199
Morgan Stanley0.00%234,182$1,604,148
Longaeva Partners L.P.0.07%217,768$1,491,711
Renaissance Technologies LLCJim Simons0.00%217,300$1,488,505
Superstring Capital Management Lp0.97%199,209$1,364,582
Jane Street Group, Llc0.00%171,375$1,173,919
Vanguard Fiduciary Trust Co0.00%158,660$1,086,821
Manufacturers Life Insurance Company, The0.00%156,317$1,070,771
Goldman Sachs Group Inc0.00%149,970$1,027,295
Verdad Advisers, Lp1.11%144,540$990,099
Bridgeway Capital Management, Llc0.02%134,300$919,955
State Street Corp0.00%132,000$904,200
Seven Fleet Capital Management Lp0.28%130,654$894,980
Northern Trust Corp0.00%127,904$876,143
Archpoint Investors0.20%121,400$831,590
Peapod Lane Capital Llc0.61%108,878$739,799
Dimensional Fund Advisors Lp0.00%104,437$714,543
Qube Research & Technologies Ltd0.00%104,217$713,886
Boothbay Fund Management, Llc0.01%92,297$632,234
683 Capital Management, Llc0.06%90,000$616,500
Ubs Group Ag0.00%85,945$588,723
Persistent Asset Partners Ltd0.19%72,325$495,426
Lpl Financial Llc0.00%60,379$413,596
Point72 Asset Management, L.P.0.00%59,090$404,767
Brevan Howard Capital Management Lp0.00%56,624$387,874
Hudson Bay Capital Management Lp0.00%54,460$373,051
Bank Of America Corp0.00%52,921$362,509
Xtx Topco Ltd0.01%51,912$355,597
Barclays Plc0.00%48,936$335,211
Squarepoint Ops Llc0.00%42,974$294,372

Frequently asked questions about ELYM

  • Who owns the most ELYM stock?

    The largest holders of ELYM are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ELIEM THERAPEUTICS INC (ELYM).

  • Is ELYM widely held by superinvestors?

    Many widely followed stocks like ELYM appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ELYM is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.